Photodynamic therapy with toluidine blue in Jurkat cells: Cytotoxicity, subcellular localization and apoptosis induction

Photochemical and Photobiological Sciences

Volumn 1, Issue 11, 2002, Pages 852-856

  Tremblay, Jean François ^a   Dussault, Sylvie ^a   Viau, Gilles ^a   Gad, Faten ^a   Boushira, Michèle ^a   Bissonnette, Robert ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CARBON 14; CASPASE 3; DNA FRAGMENT; PHOTOSENSITIZING AGENT; THIAZINE DERIVATIVE; THYMIDINE DERIVATIVE; TOLUIDINE DERIVATIVE; CASPASE; TOLONIUM CHLORIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DEGRADATION; DRUG EFFECT; DRUG MECHANISM; ELUTION; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME ACTIVITY; FILTRATION; GOLGI COMPLEX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LEUKEMIA CELL LINE; OPTICAL DENSITY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; CELL FRACTIONATION; CELL SURVIVAL; CYTOSOL; METABOLISM; METHODOLOGY; MICROSCOPY; PHOTOCHEMOTHERAPY; TIME; TOXICITY TESTING;

APOPTOSIS; CASPASES; CELL SURVIVAL; CYTOSOL; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMANS; JURKAT CELLS; MICROSCOPY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SUBCELLULAR FRACTIONS; TIME FACTORS; TOLONIUM CHLORIDE; TOXICITY TESTS;

EID: 0013435788     PISSN: 1474905X     EISSN: None     Source Type: Journal    
DOI: 10.1039/b204385h     Document Type: Article

References (40)

1. J. S. McCaughan, Photodynamic therapy: a review, Drugs Aging. 1999, 15, 49-68.
2. C. H. Sibata, V. C. Colussi, N. L. Oleinick and T. J. Kinsella, Photodynamic therapy in oncology, Expert. Opin. Pharmacother., 2001, 2, 917-927.
3. M. Wilson and N. Mia, Sensitization of Candida albicans to killing by low-power laser light, J. Oral. Pathol. Med., 1993, 22, 354-357.
4. M. Wilson, T. Burns, J. Prattent and G. Pearson, Bacteria in supragingival plaque samples can be killed by low-power laser light in the presnece of a photosensitizer, J. Appl. Bacteriol., 1995, 78, 569-574.
5. M. Wilson and C. Yanni, Killing of methicillin-resistant staphylococcus aureus by low-power laser light, J. Med. Microbiol., 1995, 42, 62-66.
6. J. L. Williams, J. Stamp, R. Devonshire and G. J. Fowler, Methylene blue and the photodynamic therapy of superficial bladder cancer, J. Photochem. Photobiol. B, 1989, 4, 229-232.
7. G. Fowler, R. Rees and R. Devonshire, The photokilling of bladder carcinoma cells in vitro by phenothiazine dyes, Photochem. Photobiol., 1990, 52, 489-494.
8. P. Herlin, J. Marnay, J. H. Jacob, J. M. Ollivier and A. M. Mandard, A study of the mechanism of the toluidine blue dye test. Endoscopy. 1983, 15, 4-7.
9. Y. Eliezri, The toluidine blue test: an aid in the diagnosis and treatment of early squamous cell carcinomas of mucous membranes, Journal of the American Academy of Dermatology, 1988, 18, 1339-1349.
10. J. B. Epstein, C. Oakley, A. Millner, S. Emerton, E. van der Meij and N. Le, The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma, Oral Surg. Oral Med. Oral Pathol., 1997, 83, 537-547.
11. I. Martin, C. Kerawala and M. Reed, The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia, Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontics, 1998, 85, 444-446.
12. R. L. Miller, B. W. Simms and A. R. Gould, Toluidine blue staining for detection of oral premalignant lesions and carcinomas. J. Oral Pathol., 1988, 17, 73-78.
13. J. Lundgren, J. Olofsson and H. Hellquist, Toluidine blue. An aid in the microlaryngoscopic diagnosis of glottic lesions?, Arch. Otolaryngol., 1979, 105, 169-174.
14. M. S. Strong, C. W. Vaughan and J. Incze, Toluidine blue in diagnosis of cancer of the larynx, Arch. Otolaryngol., 1970, 91, 515-519.
15. J. Tarkkanen, M. Paavolainen and E. Saksela, Toluidine blue staining in the endoscopic diagnosis of carcinoma of the bronchus, Ann. Clin. Res., 1972, 4, 7-9.
16. K. A. Warnakulasuriya and N. W. Johnson, Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer, J. Oral Pathol. Med., 1996, 25, 97-103.
17. A. Mashberg, Reevaluation of toluidine blue application as a diagnostic adjunct in the detection of asymptomatic oral squamous carcinoma: a continuing prospective study of oral cancer III, Cancer, 1980, 46, 758-763.
18. A. McHale and L. McHale, Use of tetrazolium-based colorimetric assay for assessing photoradiation therapy in vitro, Cancer Lett., 1988, 41, 315-321.
19. R. Bertrand and Y. Pommier, in Cell growth and apoptosis: A practical approach . ed. G. P. Studzinski, IRL Press, New York, 1995, pp. 97-118.
20. R. Bertrand, M. Sarang, J. Jenkin, D. Kerrigan and Y. Pommier, Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression, Cancer Res., 1991, 51, 6280-6285.
21. A. T. Sane and R. Bertrand, Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities, Cancer Res., 1998, 58, 3066-3072.
22. M. Garcia-Calvo, E. P. Peterson, D. M. Rasper, J. P. Vaillancourt, R. Zamboni, D. W. Nicholson and N. A. Thornberry, Purification and catalytic properties of human caspase family members, Cell Death Differ., 1999, 6, 362-369.
23. M. Wainwright, Non-porphyrin photosensitizers in biomedicine, Chem. Soc. Rev., 1996, 2, 351-358.
24. Z. Darzynkiewicz and S. P. Carter, Photosensitizing effects of the tricyclic heteroaromatic cationic dyes pyronin Y and toluidine blue O (tolonium chloride), Cancer Res., 1988, 48, 1295-1299.
25. N. S. Soukos, M. Wilson, T. Burns and P. M. Speight, Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro, Lasers Surg. Med., 1996, 18, 253-259.
26. F. Gad, G. Viau, M. Boushira, R. Bertrand and R. Bissonnette, Photodynamic therapy with 5-aminolevulinic acid induces apoptosis and caspase activation in malignant T cells, Journal of Cutaneous Medicine and Surgery, 2001, 5, 8-13.
27. M. Dellinger, Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol. Photochem. Photobiol., 1996, 64, 182-187.
28. Y. Miyamoto, Y. Umebayashi and T. Nishisaka, Comparison of phototoxicity mechanism between pulsed and continuous wave irradiation in photodynamic therapy, J. Photochem. Photobiol. B, 1999, 53, 53-59.
29. D. Kessel, Y. Luo, Y. Deng and C. K. Chang, The role of subcellular localization in initiation of apoptosis by photodynamic therapy, Photochem. Photobiol., 1997, 65, 422-426.
30. S. R. Wood, J. A. Holroyd and S. B. Brown, The subcellular localization of Zn(II) phthalocyanines and their redistribution on exposure to light, Photochem. Photobiol., 1997, 65, 397-402.
31. N. S. Trivedi, H. W. Wang, A. L. Nieminen, N. L. Oleinick and J. A. Izatt, Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy, Photochem. Photobiol., 2000, 71, 634-639.
32. G. G. Miller, K. Brown, A. M. Ballangrud, O. Barajas, Z. Xiao, J. Tulip, J. W. Lown, J. M. Leithoff, M. J. Allalunis-Turner, R. D. Mehta and R. B. Moore, Preclinical assessment of hypocrellin B and hypocrellin B derivatives its sensitizers for photodynamic therapy of cancer: progress update, Photochem. Photobiol., 1997, 65, 714-722.
33. A. J. Dunipace, R. Beaven, T. Noblitt, Y. Li, S. Zunt and G. Stookey, Mutagenic potential of toluidine blue evaluated in the Ames test, Mutat. Res., 1992, 279, 255-259.
34. J. Y. Matroule, C. M. Carthy, D. J. Granville, O. Jolois, D. W. Hunt and J. Piette, Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methyl ester photosensitization, Oncogene, 2001, 20, 4070-4084.
35. W. L. Rumboltz, C. F. Moon, J. C. Novelli and A. B. Omaha, Use of protamine sulfate and toluidine blue for abnormal uterine bleeding, Am. J. Obstet. Gynecol., 1952, 63, 1029-1037.
36. C. A. Lathrop and W. T. Carlisle, Oral toluidine blue in the treatment of hypermenorrhea, Am. J. Obstet. Gynecol., 1952, 64, 1376-1377.
37. W. Bickers, Toluidine blue- An evaluation in the treatment of uterine bleeding. Am. J. Obstet. Gynecol., 1953, 66, 1313-1317.
38. R. J. Hurvitz, S. L. Perzik and L. Morgenstern, In vivo staining of the parathyroid glands. A clinical Study, Arch. Surg., 1968, 97, 722-726.
39. R. M. Yeager and E. T. Krementz, Toluidine blue in identification of parathyroid glands at operation, Ann. Surg. (Chicago), 1969, 169, 829-838.
40. R. E. Moe and P. J. Klepper, Demonstration of the functional anatomy of the canine gastric antrum. II. Operative technics not requiring gastrotomy, Am. J. Surg., 1966, 111, 80-88.